Patients with COPD and type 2 inflammation receiving mepolizumab vs. placebo had decreased moderate and severe exacerbation ...

Pulmonary embolism (PE) is more common in children than previously thought, according to a study presented at the American ...

For patients with amyotrophic lateral sclerosis (ALS), rapid eye movement (REM) inhibition via receipt of antidepressant ...

Approximately 20% of patients who undergo bronchoscopic lung volume reduction (BLVR) lose the effects of the treatment within ...

Patients with pulmonary embolism (PE) who were treated with mechanical thrombectomy (MT) within 12 hours of hospital ...

Physicians can use peak expiratory flow as a first-line tool for assessing variable airflow limitations among patients with ...

About 11% of patients died or were delisted while waiting for a transplant prior to 2017, but that declined to about 8% after ...

For nurses in critical care areas, adding a team therapist can reduce burnout and improve resilience, according to a study ...

A new ATS 2025 study shows that ICU delirium tests often misclassify Spanish-speaking patients, putting them at risk of ...

New findings from the MATINEE and COPD-HELP studies suggest mepolizumab could reduce exacerbations and improve quality of ...